M. Deshpande

Influence of polymer architecture on the structure of complexes formed by PEG-tertiary amine methacrylate copolymers and phosphorothioate oligonucleotide.

S. Armes, M. Vamvakaki, S. Stolnik, 2002, Journal of controlled release : official journal of the Controlled Release Society.

Formulation and characterisation of nanosuspensions of BCS class II and IV drugs by combinative method

M. Deshpande, M. Reddy, Z. Attari, 2016 .

Targeting enteral endocrinal L-cells with dietary carbohydrates, by increasing the availability of miglitol in the intestinal lumen, leads to multi-fold enhancement of plasma glucagon-like peptide-1 levels in non-diabetic canines

M. Deshpande, V. Venkateswarlu, Arunkumar H Mantri, 2011, Drug development and industrial pharmacy.

Design and evaluation of oral bioadhesive controlled release formulations of miglitol, intended for prolonged inhibition of intestinal alpha-glucosidases and enhancement of plasma glucagon like peptide-1 levels.

M. Deshpande, R. Trivedi, V. Venkateswarlu, 2009, International journal of pharmaceutics.

Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens.

Wenlei Jiang, Steven P Schwendeman, M. Deshpande, 2005, Advanced drug delivery reviews.

Synergistic effect of ultrasound and PEI on DNA transfection in vitro.

M. Prausnitz, M. Deshpande, 2007, Journal of controlled release : official journal of the Controlled Release Society.

Copolymers of amine methacrylate with poly(ethylene glycol) as vectors for gene therapy.

S. Armes, M. Vamvakaki, S. Stolnik, 2001, Journal of controlled release : official journal of the Controlled Release Society.

The effect of poly(ethylene glycol) molecular architecture on cellular interaction and uptake of DNA complexes.

Martin C Garnett, Philip M Williams, Martyn C Davies, 2004, Journal of controlled release : official journal of the Controlled Release Society.

Enzymatically degradable prodrugs: A novel methodology for drug linkage

M. Deshpande, M. Kulkarni, B. S. Lele, 2002 .

Design and evaluation of oral bioadhesive controlled release formulations of miglitol, intended for prolonged inhibition of intestinal alpha-glucosidases and enhancement of plasma glucagon like peptide-1 levels.

M. Deshpande, R. Trivedi, V. Venkateswarlu, 2009, International journal of pharmaceutics.

Preparation and Characterization of Nanosuspension of Aprepitant by H96 Process

M. Deshpande, Sunethra Kalvakuntla, Zenab Attari, 2016, Advanced pharmaceutical bulletin.